Depo-Provera Litigation Update: Women With Meningioma Brain Tumors Eligible for Compensation

Start
A March 2024 study published by The BMJ revealed that women who were injected with Depo-Provera (medroxyprogesterone acetate) are more than five times more likely to be diagnosed with a type of brain tumor known as meningioma….
By: Hissey, Mulderig & Friend, PLLC
Previous Story

FDA Contradicts Benzene Class Actions, Highlighting Risks of Third-Party Lab Testing

Next Story

Pacific Residential Mortgage Confirms Data Breach Following Recent Ransomware Attack